vaccine efficacy

Are There Any Challenges in Using Nanotechnology for Vaccines?

While nanotechnology offers many advantages, there are also challenges:
Safety: The biocompatibility and toxicity of nanoparticles must be thoroughly evaluated to ensure safety.
Manufacturing: Scalable and cost-effective manufacturing processes need to be developed for nanoparticle-based vaccines.
Regulatory Approval: Regulatory pathways for nanoparticle-based vaccines need to be clearly defined, which can sometimes be a lengthy process.

Frequently asked queries:

Partnered Content Networks

Relevant Topics